Sowell Financial Services LLC purchased a new stake in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 92,563 shares of the company's stock, valued at approximately $1,977,000. Sowell Financial Services LLC owned 0.23% of Phibro Animal Health as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also recently modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Phibro Animal Health in the 4th quarter worth $29,000. Lazard Asset Management LLC lifted its holdings in shares of Phibro Animal Health by 2,739.7% in the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after buying an additional 1,589 shares during the period. Aquatic Capital Management LLC purchased a new stake in Phibro Animal Health in the fourth quarter worth about $69,000. Virtus Fund Advisers LLC purchased a new stake in Phibro Animal Health in the fourth quarter worth about $69,000. Finally, Quantbot Technologies LP lifted its stake in Phibro Animal Health by 65.1% in the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock worth $107,000 after acquiring an additional 2,018 shares during the period. Hedge funds and other institutional investors own 99.34% of the company's stock.
Analysts Set New Price Targets
PAHC has been the subject of several research reports. BNP Paribas raised shares of Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Morgan Stanley increased their price target on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a research report on Thursday, May 8th. Finally, BNP Paribas Exane raised shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price for the company in a research report on Monday, June 16th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $20.80.
View Our Latest Research Report on Phibro Animal Health
Phibro Animal Health Stock Down 0.3%
Phibro Animal Health stock traded down $0.08 during midday trading on Friday, reaching $23.88. The company's stock had a trading volume of 247,450 shares, compared to its average volume of 207,387. The stock has a market capitalization of $967.86 million, a P/E ratio of 30.62, a PEG ratio of 0.45 and a beta of 0.74. The company has a debt-to-equity ratio of 2.67, a current ratio of 2.91 and a quick ratio of 1.23. The stock's 50-day simple moving average is $21.85 and its 200-day simple moving average is $21.92. Phibro Animal Health Corporation has a 52-week low of $16.16 and a 52-week high of $26.55.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. The business had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. On average, sell-side analysts expect that Phibro Animal Health Corporation will post 1.95 EPS for the current year.
Phibro Animal Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.01%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's payout ratio is 61.54%.
Phibro Animal Health Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Articles
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
